Broken but not beaten: Unraveling the biotransformation fate of Mn@PCN224 nanozymes and its influence on enzymatic activity and safety at the human placenta in vitro
Source abstract
Abstract
Chronic placental inflammation has been associated with severe pregnancy complications including miscarriage, stillbirth, premature delivery, intra-uterine growth restriction, and recurrence risk in future pregnancies. Treatments are essential, but current standard therapies for infections and inflammation often struggle with limited efficacy and potential side effects. Nanomaterials with enzyme-mimetic properties (nanozymes) have demonstrated impressive medical capabilities especially in inflammation treatment. Remarkably, single-atom nanozymes (SAzymes) including metal-organic frameworks (MOFs) have attracted considerable attention due to their superior substrate affinity and catalytic activity compared to conventional nanozymes. However, due to their high reactivity, nanozymes could undergo biotransformation in biological fluids and tissues, affecting their physicochemical properties and potentially compromising their therapeutic efficacy and safety. On this basis, we performed a systematic study on the chemical and structural biotransformation, catalytic activity and biological impact of a PCN224 MOF at the human placenta in vitro . We engineered a PCN224 MOF, composed of zirconium clusters (Zr 6 ) and 4-carboxyphenyl-porphyrin (H 2 TCPP), further doping it with Mn (Mn@PCN224) to form Mn-TCPP complexes. These complexes mimic the natural Mn-superoxide dismutase (MnSOD), a crucial enzyme to detoxify cells from radical stress during inflammation. In biological media, Mn@PCN224 underwent rapid and substantial decomposition, leading to a significant release of Mn-TCPP complexes. Nonetheless, despite the observed biotransformation, the SOD activity was maintained, mostly by the free Mn-TCPP bearing the enzyme-like active center. We further revealed that Mn@PCN224 SAzymes and their biotransformation products did not compromise cell viability, barrier integrity and endocrine function in an in vitro human placenta co-culture model. The current findings provide crucial insights about the biotransformation mechanism of a MOF-based SAzyme and emphasize the importance of biostability assessment, in addition to efficacy and safety evaluation.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Advanced Nanomaterials in Catalysis · Nanocluster Synthesis and Applications · Advanced biosensing and bioanalysis techniques
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Nanozyme-based medicine for enzymatic therapy: progress and challenges10.1088/1748-605X/abe7b4 ↗
2. Nanozymes: activity origin, catalytic mechanism, and biological application10.1016/j.ccr.2021.214170 ↗
3. When nanozymes meet single-atom catalysis10.1002/anie.201905645 ↗
4. Single-atom catalysts across the periodic table10.1021/acs.chemrev.0c00576 ↗
5. Qiao B., Wang A., Yang X., Allard L.F., Jiang Z., Cui Y., et al. Single-atom catalysis of CO oxidation using Pt1/FeOx. Nature Chemistry 2011 3:8 [Internet]. 2011 Jul 22 [cited 2024 Jul 4];3(8):634–41. Available from: 〈https://www.nature.com/articles/nchem.1095〉.10.1038/nchem.1095 ↗
6. Metal-organic frameworks as a good platform for the fabrication of single-atom catalysts10.1021/acscatal.0c01459 ↗
7. Highly active and stable single-atom cu catalysts supported by a metal-organic framework10.1021/jacs.8b11386 ↗
8. From metal–organic frameworks to single-atom fe implanted n-doped porous carbons: efficient oxygen reduction in both alkaline and acidic media10.1002/anie.201803262 ↗
9. An enzyme-mimicking single-atom catalyst as an efficient multiple reactive oxygen and nitrogen species scavenger for sepsis management10.1002/anie.201912182 ↗
10. Single Pt atoms confined into a metal–organic framework for efficient photocatalysis10.1002/adma.201705112 ↗
11. Efficient visible-light-driven carbon dioxide reduction by a single-atom implanted metal–organic framework10.1002/anie.201608597 ↗
12. Artificial-enzymes-armed Bifidobacterium longum probiotics for alleviating intestinal inflammation and microbiota dysbiosis10.1038/s41565-023-01346-x ↗
13. Ca/Fe-based nanozymes relieve severe acute pancreatitis by ferroptosis regulation and reactive oxygen species scavenging10.1021/acsanm.3c01697 ↗
14. Bifunctional cascading nanozymes based on carbon dots promotes photodynamic therapy by regulating hypoxia and glycolysis10.1021/acsnano.3c03169 ↗
15. Drug Products, Including Biological Products, that Contain Nanomaterials Guidance for Industry Contains Nonbinding Recommendations. 2022 [cited 2024 Feb 28]; Available from: 〈https://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/default.htmand/or〉.
16. Biochemical transformations of inorganic nanomedicines in buffers, cell cultures and organisms10.1039/D3NR03415A ↗
17. The nano-bio interactions of nanomedicines: understanding the biochemical driving forces and redox reactions10.1021/acs.accounts.9b00126 ↗
18. Endoplasmic reticulum stress induced by zinc oxide nanoparticles is an earlier biomarker for nanotoxicological evaluation10.1021/nn406184r ↗
19. Comparison of the mechanism of toxicity of zinc oxide and cerium oxide nanoparticles based on dissolution and oxidative stress properties10.1021/nn800511k ↗
20. Nanoparticle cytotoxicity depends on intracellular solubility: comparison of stabilized copper metal and degradable copper oxide nanoparticles10.1016/j.toxlet.2010.05.012 ↗
21. Engineered graphene oxide nanocomposite capable of preventing the evolution of antimicrobial resistance10.1021/acsnano.9b04970 ↗
22. Molecular mechanisms, characterization methods, and utilities of nanoparticle biotransformation in nanosafety assessments10.1002/smll.201907663 ↗
23. Degradation of ZIF-8 in phosphate buffered saline media10.1039/C9CE00757A ↗
24. Nanoanalytical insights into the stability, intracellular fate, and biotransformation of metal-organic frameworks10.1021/acsami.3c08818 ↗
25. Cellular fate and performance of group IV metal organic framework radioenhancers10.1039/D2BM00973K ↗
26. Protein corona-mediated inhibition of nanozyme activity: impact of protein shape10.1021/jacs.3c14046 ↗
27. Intracellular activation of bioorthogonal nanozymes through endosomal proteolysis of the protein corona10.1021/acsnano.0c00629 ↗
28. Protein aggregation on metal oxides governs catalytic activity and cellular uptake
29. Plasma proteome association and catalytic activity of stealth polymer-grafted iron oxide nanoparticles10.1002/smll.201701528 ↗
30. Safety landscape of therapeutic nanozymes and future research directions10.1002/advs.202407816 ↗
31. Use of paracetamol during pregnancy and child neurological development10.1111/dmcn.12745 ↗
32. Epidemiology of medications use in pregnancy10.1053/j.semperi.2015.08.002 ↗
33. Actively targeted nanomedicines: a new perspective for the treatment of pregnancy-related diseases10.1007/s43032-024-01520-z ↗
34. Nanoparticles dysregulate the human placental secretome with consequences on angiogenesis and vascularization10.1002/advs.202401060 ↗
35. Enhanced peroxidase-like activity of Fe@PCN-224 nanoparticles and their applications for detection of H2O2and glucose10.1016/j.colsurfa.2019.06.012 ↗
36. Batinić-haberle · 2016
37. Erythrocyte membrane-camouflaged PCN-224 nanocarriers integrated with platinum nanoparticles and glucose oxidase for enhanced tumor sonodynamic therapy and synergistic starvation therapy10.1021/acsami.1c05644 ↗
38. A porphyrin-MOF-based integrated nanozyme system for catalytic cascades and light-enhanced synergistic amplification of cellular oxidative stress10.1039/D3TB00681F ↗
39. Porphyrinic metal-organic framework PCN-224 nanoparticles for near-infrared-induced attenuation of aggregation and neurotoxicity of Alzheimer’s Amyloid-β Peptide10.1021/acsami.8b15452 ↗
40. Space-confined nanozyme with cascade reaction based on PCN-224 for synergistic bacterial infection treatment and NIR fluorescence imaging of wound bacterial infections10.1016/j.cej.2024.150642 ↗
41. Zirconium-Metalloporphyrin PCN-222: mesoporous metal–organic frameworks with ultrahigh stability as biomimetic catalysts10.1002/anie.201204475 ↗
42. A highly stable porphyrinic zirconium metal-organic framework with shp-a topology10.1021/ja510525s ↗
43. Zr-based metal-organic frameworks: design, synthesis, structure, and applications10.1039/C5CS00837A ↗
44. Construction of ultrastable porphyrin Zr metal-organic frameworks through linker elimination10.1021/ja408084j ↗
45. Size-controlled synthesis of porphyrinic metal-organic framework and functionalization for targeted photodynamic therapy10.1021/jacs.6b00007 ↗
46. A.T.C.C. F-12K Medium (Kaighn’s Modification of Ham’s F-12 Medium) [Internet]. 2024 [cited 2025 Feb 26]. Available from: 〈https://www.atcc.org/products/30-2004#detailed-product-information〉.
47. An advanced human in vitro co-culture model for translocation studies across the placental barrier10.1038/s41598-018-23410-6 ↗
48. Importance of physicochemical characterization of nanoparticles in pharmaceutical product development10.1016/B978-0-12-817909-3.00010-8 ↗
49. Systematic comparison of commercial uranyl-alternative stains for negative- and positive-staining transmission electron microscopy of organic specimens
50. Infrared and Raman spectroscopic characterization of porphyrin and its derivatives
51. Resonance Raman spectra of dioxygen adducts of manganese(II) porphyrins in dioxygen matrices10.1002/jrs.1250220603 ↗
52. Quantum chemistry-based analysis of the vibrational spectra of five-coordinate metalloporphyrins [M(TPP)CI]10.1021/ic0510866 ↗
53. Resonance resins raman spectra of manganese-porphyrins catalytic on ion-exchange exhibiting
54. A new zirconium inorganic building brick forming metal organic frameworks with exceptional stability10.1021/ja8057953 ↗
55. 5,10,15,20-tetrakis(4-carboxyphenyl)porphyrin covalently bound to nano-silica surface: preparation, characterization and chemosensor application to detect TNT10.1007/s12633-015-9304-9 ↗
56. Photodegradation of 1,5-DHN to juglone as a biocompatible compound, using a metalloporphyrin-based mixed metal–metal organic framework: synthesis, characterization, and photocatalytic behavior10.1007/s11051-024-06138-5 ↗
57. Metalloporphyrin-based Ni/Co metal–organic framework: preparation, characterization and photodegradation of 1,5-DHN10.1007/s00289-024-05158-4 ↗
58. Policar C. Mimicking SOD, Why and How: Bio-Inspired Manganese Complexes as SOD Mimic. 2016;125–164.10.1007/978-3-319-30705-3_7 ↗
59. Integrated cascade nanozyme catalyzes in vivo ROS scavenging for anti-inflammatory therapy10.1126/sciadv.abb2695 ↗
60. Evaluation of the compounds commonly known as superoxide dismutase and catalase mimics in cellular models10.1016/j.jinorgbio.2021.111431 ↗
61. Mn-modified porphyrin metal–organic framework mediated colorimetric and photothermal dual-channel probe for sensitive detection of organophosphorus pesticides10.1016/j.jcis.2024.02.062 ↗
62. The Mn-modified porphyrin metal-organic framework with enhanced oxidase-like activity for sensitively colorimetric detection of glutathione10.1016/j.bios.2022.114446 ↗
63. Size- and shape-dependent cytotoxicity of nano-sized Zr-based porphyrinic metal-organic frameworks to macrophages10.1016/j.scitotenv.2022.155309 ↗
64. Postsynthetic ligand and cation exchange in robust metal-organic frameworks10.1021/ja3079219 ↗
65. Transmetalation: routes to metal exchange within metal–organic frameworks10.1039/c3ta10784a ↗
66. On-surface porphyrin transmetalation with Pb/Cu redox exchange10.1039/D1NR04180K ↗
67. Limited proteolysis of myoglobin opens channel in ferrochelatase-globin complex for iron to zinc transmetallation10.1016/j.foodchem.2016.04.109 ↗
68. Interplay between acetate ions, peripheral groups, and reactivity of the core nitrogens in transmetalation of tetrapyrroles10.1002/chem.200800991 ↗
69. Effect of the electrolyte on the oxygen reduction reaction with a MOF embedded co-porphyrin10.1002/cssc.202402295 ↗
70. Kinetics and mechanism of formation of nickel(II)porphyrin and its interaction with DNA in aqueous medium10.1007/s12039-021-01945-y ↗
71. Metalloporphyrins in medicine: from history to recent trends10.1021/acsabm.0c00941 ↗
72. Metalloporphyrin-encapsulated biodegradable nanosystems for highly efficient magnetic resonance imaging-guided sonodynamic cancer therapy10.1021/jacs.6b11846 ↗
73. A recyclable Mn–porphyrin catalyst for enantioselective epoxidation of unfunctionalized olefins using molecular dioxygen10.1039/C6NJ00808A ↗
74. MOF nanozymes: active sites and sensing applications
75. Metal–organic framework based nanozymes: promising materials for biochemical analysis10.1039/D0CC04890A ↗
76. MOF-encapsulated copper-doped carbon dots nanozymes with excellent biological activity promote diabetes wound healing10.1093/rb/rbae119 ↗
77. Mn porphyrin-based superoxide dismutase (SOD) mimic, MnIIITE-2-PyP5+, targets mouse heart mitochondria10.1016/j.freeradbiomed.2007.01.019 ↗
78. Porphyrins as catalysts in scalable organic reactions10.3390/molecules21030310 ↗
79. HO-1 is located in liver mitochondria and modulates mitochondrial heme content and metabolism10.1096/fj.05-4204fje ↗
80. Surface modification of zirconium alloy implants by collagen encapsulated strontium ranelate@PCN-224 coating to improve biocompatibility and promote osseointegration10.1016/j.matchemphys.2022.126910 ↗
81. Constructing fluorine-doped Zr-MOF films on titanium for antibacteria, anti-inflammation, and osteogenesis10.1016/j.msec.2022.112699 ↗
82. Nanozymes for regenerative medicine
83. Quantitative volumetric Raman imaging of three dimensional cell cultures10.1038/ncomms14843 ↗
84. Unveiling cancer metabolism through spontaneous and coherent raman spectroscopy and stable isotope probing10.3390/cancers13071718 ↗
85. MnTBAP inhibits bleomycin-induced pulmonary fibrosis by regulating VEGF and Wnt signaling10.1002/jcp.25608 ↗
86. MnTBAP inhibits bone loss in ovariectomized rats by reducing mitochondrial oxidative stress in osteoblasts10.1007/s00774-019-01038-4 ↗
87. Role of mitochondrial oxidative stress in modulating the expressions of aquaporins in obstructive kidney disease10.1152/ajprenal.00234.2017 ↗
88. Boron nitride nanosheets induce lipid accumulation and autophagy in human alveolar lung epithelial cells cultivated at air-liquid interface10.1002/smll.202308148 ↗
89. Understanding the kinetics of macrophage uptake and the metabolic fate of iron-carbohydrate complexes used for iron deficiency anemia treatment
90. SOD therapeutics: latest insights into their structure-activity relationships and impact on the cellular redox-based signaling pathways10.1089/ars.2012.5147 ↗
91. Maternal and cord blood manganese concentrations and early childhood neurodevelopment among residents near a mining-impacted superfund site
92. Placental concentrations of manganese and the risk of fetal neural tube defects10.1016/j.jtemb.2013.04.001 ↗
93. Nonclinical safety and toxicokinetics of MnTnBuOE-2-PyP5+ (BMX-001)10.1177/1091581816642766 ↗
94. A nonclinical safety assessment of MnTE-2-PyP, a manganese porphyrin10.1177/1091581813490203 ↗
95. Nonclinical safety and toxicokinetics of MnTE-2-PyP (BMX-010), a topical agent in phase 2 trials for psoriasis and atopic dermatitis10.1177/1091581819852325 ↗
96. Manganese porphyrin-based treatment improves fetal-placental development and protects against oxidative damage and NLRP3 inflammasome activation in a rat maternal hypothyroidism model10.1016/j.redox.2024.103238 ↗
97. Interference of engineered nanoparticles with in vitro toxicity assays10.1007/s00204-012-0837-z ↗
98. Toxicity screenings of nanomaterials: challenges due to interference with assay processes and components of classic in vitro tests10.3109/17435390.2013.829590 ↗
99. Effect of poly(styrene sulfonate) treatment on the structural evolution and sonodynamic performance of PCN-224 nanoparticles10.1016/j.colsurfa.2024.133603 ↗
100. Physiologic and pharmacokinetic changes in pregnancy10.3389/fphar.2014.00065 ↗